A phase II study of recombinant interferon-beta (r-hIFN-beta 1a) in combination with 5-fluorouracil (5-FU) in the treatment of patients with advanced colorectal carcinoma.

The combination of 5-fluorouracil (5-FU) and interferon-alpha (IFN-alpha) has reported activity in the treatment of advanced colorectal carcinoma. Laboratory studies of IFN-beta suggest that this agent may offer theoretical advantages over IFN-alpha in combination with 5-FU. A total of 27 patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Joffe, J. K., Perren, T. J., Bradley, C., Primrose, J., Hallam, S., Ward, U., Illingworth, J. M., Selby, P. J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063373/
https://www.ncbi.nlm.nih.gov/pubmed/9020490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063373/
https://www.ncbi.nlm.nih.gov/pubmed/9020490

Ejemplares similares